Members of CRF family and their receptors: from past to future.

Abstract:

:Corticotropin releasing factor (CRF), originally isolated from the mammalian hypothalamus, is a 41 amino acid peptide that plays an important physiological role and is implicated in the pathophysiology of various diseases. In addition to CRF and its related peptides, a large number of small non-peptide CRF analogs have been recently synthesized, some currently in clinical trials having considerable therapeutic potential in the treatment of CRF-related illnesses. CRF and its related peptides exert their multiple actions by interacting with two types of plasma membrane G-protein coupled CRF receptors, the type 1 (CRF(1)) and type 2 (CRF(2)). These receptors, like all GPCRs consist of an amino-terminal extracellular region, a carboxyl-terminal intracellular tail and seven, membrane-spanning segments, connected by alternating intracellular and extracellular loops. This review describes the functional role of CRF receptors and their ligands emphasizing the structural elements that are important for their function and could potentially contribute in the development of future target-based approaches to design new CRF-related drugs which will enrich the pharmaceutical armoire against serious diseases.

journal_name

Curr Med Chem

authors

Liapakis G,Venihaki M,Margioris A,Grigoriadis D,Gkountelias K

doi

10.2174/092986711795933704

subject

Has Abstract

pub_date

2011-01-01 00:00:00

pages

2583-600

issue

17

eissn

0929-8673

issn

1875-533X

pii

BSP/CMC/E-Pub/2011/ 198

journal_volume

18

pub_type

杂志文章,评审
  • Cholesterol Efflux and Reverse Cholesterol Transport: Experimental Approaches.

    abstract:BACKGROUND:Cholesterol efflux as a key event in reverse cholesterol transport (RCT) is considered now as both diagnostic tool and a promising target for the treatment of atherosclerosis. Radioactive in vitro cholesterol efflux assay (CEA) is the gold standard for determination of efflux at cellular level. Fluorescent t...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867323666160809093009

    authors: Litvinov DY,Savushkin EV,Garaeva EA,Dergunov AD

    更新日期:2016-01-01 00:00:00

  • New methods for medicinal chemistry--universal gene cloning and expression systems for production of marine bioactive metabolites.

    abstract::Natural products from symbiotic or commensal associations between marine invertebrate and microbial organisms show exceptional promise as pharmaceuticals in many therapeutic areas. An economic and sustainable global market supply due to difficulty of synthesis is cited as the main obstacle for exploitation of these ot...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986706776055643

    authors: Dunlap WC,Jaspars M,Hranueli D,Battershill CN,Perić-Concha N,Zucko J,Wright SH,Long PF

    更新日期:2006-01-01 00:00:00

  • Molecular targeted therapy in enteropancreatic neuroendocrine tumors: from biology to clinical practice.

    abstract::Advanced enteropancreatic (EP) neuroendocrine tumors (NETs) can be treated with several different therapies, including chemotherapy, biotherapy, and locoregional treatments. Over the last few decades, impressive progress has been made in the biotherapy field. Three main druggable molecular targets have been studied an...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/09298673113209990237

    authors: Fazio N,Scarpa A,Falconi M

    更新日期:2014-01-01 00:00:00

  • Environmental chemicals and breast cancer risk--a structural chemistry perspective.

    abstract::In modern industrialized societies, people are exposed to thousands of naturally occurring and synthetic chemicals throughout their lifetime. Although certain occupational chemicals are known to be carcinogenic in humans, it has been difficult to definitively determine the adverse health effects of many environmental ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986708786242930

    authors: Weyandt J,Ellsworth RE,Hooke JA,Shriver CD,Ellsworth DL

    更新日期:2008-01-01 00:00:00

  • Subtype-selective dopamine receptor radioligands for PET imaging: current status and recent developments.

    abstract::This review presents a general overview of the subtype-selective dopamine receptor radioligands for in vivo imaging of dopamine receptor expression by positron emission tomography (PET). Besides the (11)C- and (18)F-labeled radioligands which are already in clinical use, a summary of subtype-selective radioligands whi...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986712802002518

    authors: Banerjee A,Prante O

    更新日期:2012-01-01 00:00:00

  • A closer look into G protein coupled receptor activation: X-ray crystallography and long-scale molecular dynamics simulations.

    abstract::G protein coupled receptors (GPCRs) are a large eukaryotic protein family of transmembrane receptors that react to a signal coming from the extracellular environment to generate an intracellular response through the activation of a signal transduction pathway mediated by a heterotrimeric G protein. Their diversity, di...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986712799320493

    authors: Vanni S,Rothlisberger U

    更新日期:2012-01-01 00:00:00

  • New targets for antibacterial design: Kdo biosynthesis and LPS machinery transport to the cell surface.

    abstract::Lipopolysaccharide (LPS), which constitutes the lipid portion of the outer leaflet of Gram-negative bacteria, is essential for growth. It is also responsible for the variety of biological effects associated with Gram-negative sepsis. Recent advances have elucidated the exact chemical structure of this highly complex m...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711794927676

    authors: Cipolla L,Polissi A,Airoldi C,Gabrielli L,Merlo S,Nicotra F

    更新日期:2011-01-01 00:00:00

  • 2-Arylbenzothiazole as a privileged scaffold in drug discovery.

    abstract::Substituted 2-arylbenzothiazoles have emerged in recent years as an important pharmacophore in a number of diagnostic and therapeutic settings. Attractive features of drug candidates based on this benzothiazole scaffold include their synthetic accessibility, and synthetic approaches to 2-arylbenzothiazole-based compou...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986709788682137

    authors: Weekes AA,Westwell AD

    更新日期:2009-01-01 00:00:00

  • Receptor tyrosine kinase kit and gastrointestinal stromal tumours: an overview.

    abstract::Kit is a growth factor receptor of the type III tyrosine kinase family, whose gain-of-function mutations have been identified as driving causes of different kinds of tumours. It thus represents a viable drug target, and the development of Kit inhibitors has been shown to be a promising therapeutic concept. This review...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711796150504

    authors: Sartini S,Dario B,Morelli M,Da Settimo F,La Motta C

    更新日期:2011-01-01 00:00:00

  • Novel Inflammatory Markers in Hyperlipidemia: Clinical Implications.

    abstract::Hyperlipidemia is characterized by abnormally increased plasma of any or all lipids and /or lipoproteins and is a confirmed risk factor for the formation of atherosclerosis. Inflammation plays a crucial role in the formation and progression of atherosclerosis and consequently on cardiovascular diseases. Nowadays, the ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867322666150520095008

    authors: Papapanagiotou A,Siasos G,Kassi E,Gargalionis AN,Papavassiliou AG

    更新日期:2015-01-01 00:00:00

  • Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer's Disease and Less Well-Known Diseases.

    abstract::The discovery of cannabinoid receptors at the beginning of the 1990s, CB1 cloned in 1990 and CB2 cloned in 1993, and the availability of selective and potent cannabimimetics could only be justified by the existence of endogenous ligands that are capable of binding to them. Thus, the characterisation and cloning of the...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867325666180226095132

    authors: Páez JA,Campillo NE

    更新日期:2019-01-01 00:00:00

  • The Typical Metabolic Modifiers Conferring Improvement in Cancer Resistance.

    abstract:BACKGROUND:Cancer metabolic reprogramming rekindles enthusiasm for the research of metabolic regulation in cancer drug resistance. A growing number of metabolic modifiers combined with cancer drugs obtain the expected efficacy in in vitro or in vivo studies, also in clinical trial studies, indicating a good potential o...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666170203121449

    authors: Tan W,Zhong Z,Wang S,Liu H,Yu H,Tan R,Hu X,Pan T,Wang Y

    更新日期:2017-11-17 00:00:00

  • Genistein aglycone: a dual mode of action anti-osteoporotic soy isoflavone rebalancing bone turnover towards bone formation.

    abstract::Osteoporosis is characterized by reduced bone mass and structural deterioration of bone tissue leading to enhanced bone fragility and a consequent increase in fracture risk. Bone loss further increases in postmenopausal women when the ovaries stop making estrogens. Women undergoing treatment for osteoporosis require l...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986710791959738

    authors: Bitto A,Polito F,Squadrito F,Marini H,D'Anna R,Irrera N,Minutoli L,Granese R,Altavilla D

    更新日期:2010-01-01 00:00:00

  • Chemistry and biology of pyoverdines, Pseudomonas primary siderophores.

    abstract::Pyoverdine is the generic name given to a vast family of fluorescent green-yellowish pigments produced by Pseudomonas species. Pseudomonas aeruginosa is an opportunistic pathogen, particularly infecting humans with compromised natural defenses. These infections result in significantly higher morbidity, longer hospital...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/0929867321666141011194624

    authors: Cézard C,Farvacques N,Sonnet P

    更新日期:2015-01-01 00:00:00

  • Transcription factors as targets for DNA-interacting drugs.

    abstract::Gene expression, both tissue specific or inducible, is controlled at the level of transcription by various transcription factors interacting with specific sequences of DNA. Anticancer drugs and other potential therapeutic agents alter interactions of regulatory proteins with DNA by a variety of different mechanisms. T...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867033457683

    authors: Gniazdowski M,Denny WA,Nelson SM,Czyz M

    更新日期:2003-06-01 00:00:00

  • Aptamers as therapeutics in cardiovascular diseases.

    abstract::With many advantages over other therapeutic agents such as monoclonal antibodies, aptamers have recently emerged as a novel and powerful class of ligands with excellent potential for diagnostic and therapeutic applications. Typically generated through Systematic Evolution of Ligands by EXponential enrichment (SELEX), ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986711797189673

    authors: Wang P,Yang Y,Hong H,Zhang Y,Cai W,Fang D

    更新日期:2011-01-01 00:00:00

  • A Systematic Review on Anti-diabetic Properties of Chalcones.

    abstract::The use of anti-diabetic drugs has been increasing worldwide and the evolution of therapeutics has been enormous. Still, the currently available anti-diabetic drugs do not present the desired efficacy and are generally associated with serious adverse effects. Thus, entirely new interventions, addressing the underlying...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/0929867325666181001112226

    authors: Rocha S,Ribeiro D,Fernandes E,Freitas M

    更新日期:2020-01-01 00:00:00

  • A Systematic Analysis of Physicochemical and ADME Properties of All Small Molecule Kinase Inhibitors Approved by US FDA from January 2001 to October 2015.

    abstract:BACKGROUND:During lead identification and optimization, the advancement criteria may be driven based on scientific principles, prior experiences, and/or by examining the path paved by approved drugs. However, accessing the discovery data on physicochemical and ADME properties of the approved kinase inhibitors is a monu...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666170523124441

    authors: O Brien Z,Moghaddam MF

    更新日期:2017-01-01 00:00:00

  • Recent Advances in the Development of Pharmaceutical Agents for Metabolic Disorders: A Computational Perspective.

    abstract:BACKGROUND:Metabolic disorders comprise a set of different disorders varying from epidemic diseases such as diabetes mellitus to inborn metabolic orphan diseases such as phenylketonuria. Despite considerable evidence showing the importance of the computational methods in discovery and development of new pharmaceuticals...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666171002120647

    authors: Janardhan S,Dubovskaja V,Lagunin A,Rao BV,Sastry GN,Poroikov V

    更新日期:2018-01-01 00:00:00

  • Isoform selective voltage-gated sodium channel modulators and the therapy of pain.

    abstract::Voltage-gated sodium channels are large transmembrane protein complexes responsible for the propagation and transmission of electrical impulses through nerve, muscle and endocrine cells and cell systems. Dysregulated expression and/or functional changes of ion channel isoforms are found in many associated pathological...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/09298673113206660257

    authors: Jukič M,Kikelj D,Anderluh M

    更新日期:2014-01-01 00:00:00

  • Current progress in the chemistry and pharmacology of akuammiline alkaloids.

    abstract::Akuammiline alkaloids are a family of monoterpene indole alkaloids of renewed medicinal interest. These bases act as ligands for a heterogeneous group of molecular targets and, consequently, display a wide variety of pharmacological activities. For example, pseudoakuammigine (2) exhibits opioid activity in vivo, echit...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867033457016

    authors: Ramírez A,García-Rubio S

    更新日期:2003-09-01 00:00:00

  • Natural COX-2 inhibitors as promising anti-inflammatory agents: an update.

    abstract::COX-2, a key enzyme that catalyzed the rate-limiting steps in the conversion of arachidonic acid to prostaglandins, played a pivotal role in inflammatory process. Different from other family members, COX-2 was barely detectable in normal physiological conditions and highly inducible during acute inflammatory response ...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/0929867327999200917150939

    authors: Cui J,Jia J

    更新日期:2020-09-17 00:00:00

  • Discovery and Development of Non-Dopaminergic Agents for the Treatment of Schizophrenia: Overview of the Preclinical and Early Clinical Studies.

    abstract::Schizophrenia is a chronic psychiatric disorder that affects about 1 in 100 people around the world and results in persistent emotional and cognitive impairments. Untreated schizophrenia leads to deterioration in quality of life and premature death. Although the clinical efficacy of dopamine D2 receptor antagonists ag...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867326666190710172002

    authors: Jankowska A,Satała G,Partyka A,Wesołowska A,Bojarski AJ,Pawłowski M,Chłoń-Rzepa G

    更新日期:2019-01-01 00:00:00

  • Natural and synthetic biologically active dimeric molecules: anticancer agents, anti-HIV agents, steroid derivatives and opioid antagonists.

    abstract::Symmetry plays a crucial role in a variety of biological processes. For instance, many protein receptors, upon activation, dimerize to its active form and subsequently produce its biological action. Hence, there is a renewal of curiosity for the synthesis of dimeric molecules (or bivalent ligands) capable, not only to...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986706775197908

    authors: Bérubé G

    更新日期:2006-01-01 00:00:00

  • New Perspectives of Machine Learning in Drug Discovery.

    abstract::Artificial intelligence methods, in particular, machine learning, has been playing a pivotal role in drug development, from structural design to clinical trial. This approach is harnessing the impact of computer-aided drug discovery thanks to large available data sets for drug candidates and its new and complex manner...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章

    doi:10.2174/0929867327666201111144048

    authors: Musella S,Verna G,Fasano A,Di Micco S

    更新日期:2020-11-11 00:00:00

  • The glioblastoma problem: targeting by combined medicinal chemistry approaches.

    abstract::Whilst knowledge of basic biology, diagnosis and prognosis of glioblastoma (GB - WHO grade IV) are steadily improving, advancements of therapy are discouragingly slow, with the only significant novelty during last ten years represented by introduction of temozolomide in chemotherapy. In order to analyze the current st...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867322666150530210700

    authors: Frosina G

    更新日期:2015-01-01 00:00:00

  • Linear Peptides in Intracellular Applications.

    abstract::To this point, efforts to develop therapeutic peptides for intracellular applications were guided by the perception that unmodified linear peptides are highly unstable and therefore structural modifications are required to reduce proteolytic breakdown. Largely, this concept is a consequence of the fact that most resea...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867324666170508143523

    authors: Zuconelli CR,Brock R,Adjobo-Hermans MJW

    更新日期:2017-01-01 00:00:00

  • Targeting the BH3 domain of Bcl-2 family proteins. A brief history from natural products to foldamers as promising cancer therapeutic avenues.

    abstract::For many years the spotlight in drug discovery has been on a relatively small number of validated therapeutic target classes, such as G-protein coupled receptors and enzymes such as protein kinases, with well characterized enzymatic and cellular activities. However, with recent progress in genomics and proteomics, pro...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/0929867311320240003

    authors: De Giorgi M,Voisin-Chiret AS,Rault S

    更新日期:2013-01-01 00:00:00

  • Targeting tumor lymphangiogenesis: an update.

    abstract::Various human tumors preferentially metastasize by lymphatic route and lymphovascular invasion predicts lymph node metastasis. In this review article, we will summarize recent literature data concerning lymphangiogenesis, focusing on tumor lymphangiogenesis. In detail, we try to answer some important questions related...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986710790514471

    authors: Raica M,Ribatti D

    更新日期:2010-01-01 00:00:00

  • 3,4-DGE is important for side effects in peritoneal dialysis what about its role in diabetes.

    abstract::Breakdown of glucose under physiological conditions gives rise to glucose degradation products (GDPs). GDPs are also formed during heat sterilization of glucose-containing peritoneal dialysis fluids (PD-fluids). In PD-fluids GDPs have been shown in many different in vitro assays to be responsible for adverse effects s...

    journal_title:Current medicinal chemistry

    pub_type: 杂志文章,评审

    doi:10.2174/092986706778201576

    authors: Ortiz A,Wieslander A,Linden T,Santamaria B,Sanz A,Justo P,Sanchez-Niño MD,Benito A,Kjellstrand P

    更新日期:2006-01-01 00:00:00